The test — which identifies esophageal, liver, lung, ovarian, pancreatic and stomach cancers — showed overall sensitivity of 86 percent at a specificity of 95 percent in initial results. Its sensitivity was 89 percent for esophageal cancer, 83 percent for liver cancer, 78 percent for lung cancer, 90 percent for ovarian cancer, 90 percent for pancreatic cancer, and 87 percent for stomach cancer.
Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test